These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29053717)

  • 21. Design, synthesis and biological evaluation of indane derived GPR40 agoPAMs.
    Pio B; Chobanian HR; Guo Y; Josien H; Hagmann WK; Miller M; Trujillo ME; Kirkland M; Kosinski D; Mane J; Pachanski M; Cheewatrakoolpong B; Ashley E; Orr R; Wright MJ; Bugianesi R; Souza S; Zhang X; Di Salvo J; Weinglass AB; Tschirret-Guth R; Samuel K; Chen Q; Shang J; Lamca J; Ehrhart J; Nargund R; Howard AD; Colletti SL
    Bioorg Med Chem Lett; 2019 Jul; 29(14):1842-1848. PubMed ID: 31109791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. β-Cell Inactivation of
    Panaro BL; Flock GB; Campbell JE; Beaudry JL; Cao X; Drucker DJ
    Diabetes; 2017 Jun; 66(6):1626-1635. PubMed ID: 28254842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new synthetic dual agonist of GPR120/GPR40 induces GLP-1 secretion and improves glucose homeostasis in mice.
    Bianchini G; Nigro C; Sirico A; Novelli R; Prevenzano I; Miele C; Beguinot F; Aramini A
    Biomed Pharmacother; 2021 Jul; 139():111613. PubMed ID: 33895521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
    Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
    J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: the role of type 2 diabetes and fatty acids.
    Del Guerra S; Bugliani M; D'Aleo V; Del Prato S; Boggi U; Mosca F; Filipponi F; Lupi R
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):22-5. PubMed ID: 19758793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of new dual PPARγ-GPR40 agonists with robust antidiabetic activity: Design, synthesis and in combo drug evaluation.
    Hidalgo-Figueroa S; Navarrete-Vázquez G; Estrada-Soto S; Giles-Rivas D; Alarcón-Aguilar FJ; León-Rivera I; Giacoman-Martínez A; Miranda Pérez E; Almanza-Pérez JC
    Biomed Pharmacother; 2017 Jun; 90():53-61. PubMed ID: 28342366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GPR120 suppresses adipose tissue lipolysis and synergizes with GPR40 in antidiabetic efficacy.
    Satapati S; Qian Y; Wu MS; Petrov A; Dai G; Wang SP; Zhu Y; Shen X; Muise ES; Chen Y; Zycband E; Weinglass A; Di Salvo J; Debenham JS; Cox JM; Lan P; Shah V; Previs SF; Erion M; Kelley DE; Wang L; Howard AD; Shang J
    J Lipid Res; 2017 Aug; 58(8):1561-1578. PubMed ID: 28583918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oleic acid interacts with GPR40 to induce Ca2+ signaling in rat islet beta-cells: mediation by PLC and L-type Ca2+ channel and link to insulin release.
    Fujiwara K; Maekawa F; Yada T
    Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E670-7. PubMed ID: 15914509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potentiation of Glucose-stimulated Insulin Secretion by the GPR40-PLC-TRPC Pathway in Pancreatic β-Cells.
    Yamada H; Yoshida M; Ito K; Dezaki K; Yada T; Ishikawa SE; Kakei M
    Sci Rep; 2016 May; 6():25912. PubMed ID: 27180622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the gene for a membrane-bound fatty acid receptor in the pancreas and islet cell tumours in humans: evidence for GPR40 expression in pancreatic beta cells and implications for insulin secretion.
    Tomita T; Masuzaki H; Iwakura H; Fujikura J; Noguchi M; Tanaka T; Ebihara K; Kawamura J; Komoto I; Kawaguchi Y; Fujimoto K; Doi R; Shimada Y; Hosoda K; Imamura M; Nakao K
    Diabetologia; 2006 May; 49(5):962-8. PubMed ID: 16525841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of berberine as a novel agonist of fatty acid receptor GPR40.
    Rayasam GV; Tulasi VK; Sundaram S; Singh W; Kant R; Davis JA; Saini KS; Ray A
    Phytother Res; 2010 Aug; 24(8):1260-3. PubMed ID: 20658575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic Exposure to SCO-267, an Allosteric GPR40 Full Agonist, Is Effective in Improving Glycemic Control in Rats.
    Koyama R; Ookawara M; Watanabe M; Moritoh Y
    Mol Pharmacol; 2021 Apr; 99(4):286-293. PubMed ID: 33547250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice.
    Yoshida S; Ohishi T; Matsui T; Tanaka H; Oshima H; Yonetoku Y; Shibasaki M
    Biochem Biophys Res Commun; 2010 Nov; 402(2):280-5. PubMed ID: 20937249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse.
    Steneberg P; Rubins N; Bartoov-Shifman R; Walker MD; Edlund H
    Cell Metab; 2005 Apr; 1(4):245-58. PubMed ID: 16054069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fasiglifam/TAK-875, a Selective GPR40 Agonist, Improves Hyperglycemia in Rats Unresponsive to Sulfonylureas and Acts Additively with Sulfonylureas.
    Ito R; Tsujihata Y; Suzuki M; Miyawaki K; Matsuda K; Takeuchi K
    J Pharmacol Exp Ther; 2016 Apr; 357(1):217-27. PubMed ID: 26813930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of GPR40 in fatty acid action on the beta cell line INS-1E.
    Shapiro H; Shachar S; Sekler I; Hershfinkel M; Walker MD
    Biochem Biophys Res Commun; 2005 Sep; 335(1):97-104. PubMed ID: 16081037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Zn2+ Modulated GPR39 Receptor Agonists Do Not Drive Acute Insulin Secretion in Rodents.
    Fjellström O; Larsson N; Yasuda S; Tsuchida T; Oguma T; Marley A; Wennberg-Huldt C; Hovdal D; Fukuda H; Yoneyama Y; Sasaki K; Johansson A; Lundqvist S; Brengdahl J; Isaacs RJ; Brown D; Geschwindner S; Benthem L; Priest C; Turnbull A
    PLoS One; 2015; 10(12):e0145849. PubMed ID: 26720709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss-of-function mutation of the GPR40 gene associates with abnormal stimulated insulin secretion by acting on intracellular calcium mobilization.
    Vettor R; Granzotto M; De Stefani D; Trevellin E; Rossato M; Farina MG; Milan G; Pilon C; Nigro A; Federspil G; Vigneri R; Vitiello L; Rizzuto R; Baratta R; Frittitta L
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3541-50. PubMed ID: 18583466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and biological activity of potent and orally available G protein-coupled receptor 40 agonists.
    Sasaki S; Kitamura S; Negoro N; Suzuki M; Tsujihata Y; Suzuki N; Santou T; Kanzaki N; Harada M; Tanaka Y; Kobayashi M; Tada N; Funami M; Tanaka T; Yamamoto Y; Fukatsu K; Yasuma T; Momose Y
    J Med Chem; 2011 Mar; 54(5):1365-78. PubMed ID: 21319751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of 3-aryl-3-ethoxypropanoic acids as orally active GPR40 agonists.
    Takano R; Yoshida M; Inoue M; Honda T; Nakashima R; Matsumoto K; Yano T; Ogata T; Watanabe N; Toda N
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2949-53. PubMed ID: 24835985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.